Patent US4475916A successfully refreshed from Google Patents.
US4475916A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Osmotic drug delivery system
Assignee: Merck and Co Inc
•
Filing: 1982-03-18
•
Granted: 1984-10-09
•
Expires: 2002-03-18
Abstract
Abstract An osmotic drug (or other beneficial substance) delivery system comprises a compartment with one or more chambers in series formed by an external shell and chamber-dividing walls of a microporous material and successive overlayers of semipermeable membranes completely covering the outer shell of all but one chamber and substantially covering the outer shell of that one chamber, each successive overlayer completely covering all but one more chamber and substantially covering that one more chamber. Osmotic agents, adjuvants, enzymes, drugs, pro-drugs, pesticides and the like are incorporated in the chambers covered by the semipermeable membranes, and external fluids that diffuse into that chamber form solutions and by osmotic pressure are forced through the microporous chamber-dividing wall to the drug or drug-forming chamber to form a solution thereof and then through the exposed microporous shell to the exterior of the device at a rate controlled by the permeability of the semipermeable overlay and the osmotic pressure gradient across the shell.
Inventors
- 👤 Kenneth J. Himmelstein
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 02:17
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0002; A61K9/0004
Claims Analysis
Total Claims: 12
Claim 1
Independent Claim
84 words
An osmotic delivery system shaped and sized for oral ingestion, implantation, rectal, vaginal or ocular insertion, for delivery of a drug or other beneficial substance comprising a compartment consisting of at least one chamber, said chamber being adapted to house osmotically active agents, adsorption adjuvants, drugs, and pro-drugs, said chamber being formed by an external shell of a rigid microporous material; and at least one overlayer of a semipermeable membrane substantially covering the external shell of said chamber leaving exposed a microporous drug-emitting surface.
Claim 2
Dependent Claim
84 words
An osmotic delivery system shaped and sized for oral ingestion, implantation, rectal, vaginal or ocular insertion, for delivery of a drug or other beneficial substance comprising a compartment consisting of at least one chamber, said chamber being adapted to house osmotically active agents, adsorption adjuvants, drugs, and pro-drugs, said chamber being formed by an external shell of a rigid microporous material; and at least one overlayer of a semipermeable membrane substantially covering the external shell of said chamber leaving exposed a microporous drug-emitting surface.
Claim 3
Dependent Claim
87 words
The osmotic delivery system of claim 1, wherein said compartment consists of at least two chambers in series with chamber-dividing walls of a rigid microporous material, wherein said overlayer consists of at least two successive overlayers of a semipermeable membrane, the first overlayer completely covering the external shell of all but one chamber and substantially covering the external shell of that one chamber leaving exposed a microporous drug-emitting surface; and each successive overlayer completely covering all but one more chamber and substantially covering that one more chamber.
Claim 4
Dependent Claim
55 words
The osmotic delivery system of claim 2 shaped and sized for oral ingestion, implantation, rectal, vaginal or ocular insertion, for delivery of a drug or other beneficial substance comprising a compartment with 1 chamber or, 2 or 3 chambers in series, the chambers being adapted to house osmotically active agents, adsorption adjuvants, drugs, and pro-drugs.
Claim 5
Dependent Claim
51 words
The osmotic delivery system of claim 2 shaped and sized for oral ingestion, implantation, rectal, vaginal or ocular insertion, for delivery of a drug or other beneficial substance comprising a compartment consisting of 3 chambers in series, the chambers being adapted to house osmotically active agents, adsorption adjuvants, drugs, and pro-drugs.
Claim 6
Dependent Claim
51 words
The osmotic delivery system of claim 2 shaped and sized for oral ingestion, implantation, rectal, vaginal or ocular insertion, for delivery of a drug or other beneficial substance comprising a compartment consisting of 2 chambers in series, the chambers being adapted to house osmotically active agents, adsorption adjuvants, drugs, and pro-drugs.
Claim 7
Dependent Claim
49 words
The osmotic delivery system of claim 1 shaped and sized for oral ingestion, implantation, rectal, vaginal or ocular insertion, for delivery of a drug or other beneficial substance comprising a compartment consisting of 1 chamber, the chamber being adapted to house osmotically active agents, adsorption adjuvants, drug, and pro-drugs.
Claim 8
Dependent Claim
35 words
The delivery system of claim 2, comprising 2 chambers wherein the first chamber is adapted to house an osmotically active agent and the second chamber is adapted to house a drug or other beneficial substance.
Claim 9
Dependent Claim
54 words
The delivery system of claim 2 comprising 3 chambers wherein the first chamber is adapted to house a composition comprising an absorption adjuvant, the middle chamber is adapted to house a composition comprising an osmotically active agent and the third chamber is adapted to house a composition comprising a drug or other beneficial substance.
Claim 10
Dependent Claim
24 words
The osmotic delivery system of claim 1, further comprising a quick release loading dose of drug external to and covering said microporous drug-emitting surface.
Claim 11
Dependent Claim
25 words
The osmotic delivery system of claim 1, further comprising a cap covering said drug-emitting surface designed for spontaneous removal following establishment of desired flow characteristics.
Claim 12
Dependent Claim
19 words
The osmotic delivery system of claim 1, wherein said microporous material and said semipermeable membrane is a cellulose acetate.
References Cited (Backward Citations)
US3993071A
Cited
US3845770A
Cited
US3975350A
Cited
US3993072A
Cited
US3982536A
Cited
US4093708A
Cited
US4014334A
Cited
US4160452A
Cited
US4256108A
Cited
US4210139A
Cited
US4250611A
Cited
US4249531A
Cited
US4309996A
Cited
US4298003A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1987-10-09 | 1988-04-09 | 1988-10-09 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1991-10-09 | 1992-04-09 | 1992-10-09 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1995-10-09 | 1996-04-09 | 1996-10-09 | $7700.00 | Window Closed / Lapsed |